Clinical Trials Directory

Trials / Completed

CompletedNCT04622215

Diuresis, Functional Bladder Capacity and LUTS in CKD and ESRD Patients.

Diuresis, Functional Bladder Capacity and LUTS (Lower Urinary Tract Symptoms) in CKD (Chronic Kidney Disease) and ESRD (End Stage Renal Disease) Patients.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
128 (actual)
Sponsor
Universitair Ziekenhuis Brussel · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to evaluate the prevalence of LUTS in patients with moderate to severe (Stage IIIb), severe (Stage IV) CKD and ESRD : Stage V CKD) without renal transplantation (both pre-dialysis and dialysis patients). The study will also investigate the correlation between the diuresis, functional bladder capacity and LUTS in this population. By means of the obtained results, the investigators hope to be able to predict at which values of diuresis and functional bladder capacity these patients will start to develop LUTS. The investigators will also evaluate the impact of LUTS on the quality of life of these patients.

Detailed description

Pre-dialysis and peritoneal dialysis (home dialysis) and hemodialysis patients will be asked to fill in a 24h voiding diary the day prior to the control visit or dialysis session, or this can be registered the day of planned 24h urine collection. All patients will be asked to fill a ICIQ-LUTS questionnaire. The ICIQ-LUTS questionnaire is a validated questionnaire to investigate the presence of LUTS in a non-invasive way: ICIQ-FLUTS(female lower urinary tract symptoms) for female patients and ICIQ-MLUTS(male lower urinary tract symptoms) for male patients. Following patient data will be registered: * Age * Gender * eGFR(estimated Glomerular Filtration Rate) (CKD-EPD) * Cause of CKD-ESRD * In case of dialysis: duration modality (hemodialysis or peritoneal dialysis) * Antecedents * Comorbidities * Medication * 24h voiding diary * LUTS questionnaire

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTICIQ questionnairequestionnaire

Timeline

Start date
2019-01-01
Primary completion
2019-05-31
Completion
2019-07-01
First posted
2020-11-09
Last updated
2020-11-16

Locations

3 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04622215. Inclusion in this directory is not an endorsement.